156 related articles for article (PubMed ID: 38380081)
1. KIF26B and CREB3L1 Derived from Immunoscore Could Inhibit the Progression of Ovarian Cancer.
Cong S; Fu Y; Zhao X; Guo Q; Liang T; Wu D; Wang J; Zhang G
J Immunol Res; 2024; 2024():4817924. PubMed ID: 38380081
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of KIF26B, Cell Migration and Proliferation of Human Ovarian Cancer Cell Lines In Vitro, and Patient Outcomes from Human Bioinformatic Analysis.
Yang X; Zhang L; Xie L
Med Sci Monit; 2018 Jun; 24():3863-3872. PubMed ID: 29880787
[TBL] [Abstract][Full Text] [Related]
3. Identification of two immune subtypes and four hub immune-related genes in ovarian cancer through multiple analysis.
Tang Q; Zhang H; Tang R
Medicine (Baltimore); 2023 Oct; 102(40):e35246. PubMed ID: 37800814
[TBL] [Abstract][Full Text] [Related]
4. Identification of dysregulated miRNAs-genes network in ovarian cancer: An integrative approach to uncover the molecular interactions and oncomechanisms.
Kadkhoda S; Darbeheshti F; Tavakkoly-Bazzaz J
Cancer Rep (Hoboken); 2020 Dec; 3(6):e1286. PubMed ID: 32886452
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis identifying epithelial-derived transcriptomes predicts poor clinical outcome and immune infiltrations in ovarian cancer.
Li DF; Tulahong A; Uddin MN; Zhao H; Zhang H
Math Biosci Eng; 2021 Jul; 18(5):6527-6551. PubMed ID: 34517544
[TBL] [Abstract][Full Text] [Related]
6. Phylostratigraphic analysis of gene co-expression network reveals the evolution of functional modules for ovarian cancer.
Zhang L; Tan Y; Fan S; Zhang X; Zhang Z
Sci Rep; 2019 Feb; 9(1):2623. PubMed ID: 30796309
[TBL] [Abstract][Full Text] [Related]
7. Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer.
Li M; Shi M; Xu Y; Qiu J; Lv Q
Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
[TBL] [Abstract][Full Text] [Related]
8. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
9. ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer.
Jie Y; Ye L; Chen H; Yu X; Cai L; He W; Fu Y
Bioengineered; 2020 Dec; 11(1):872-882. PubMed ID: 32779991
[TBL] [Abstract][Full Text] [Related]
10. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
11. [Identification of Hub Genes for Ovarian Cancer Stem Cell Properties with Weighted Gene Co-expression Network Analysis].
Luo M; Zeng H; Ma XY; Ma XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):248-258. PubMed ID: 33829699
[TBL] [Abstract][Full Text] [Related]
12. Assessing of programmed cell death gene signature for predicting ovarian cancer prognosis and treatment response.
Lian X; Liu B; Wang C; Wang S; Zhuang Y; Li X
Front Endocrinol (Lausanne); 2023; 14():1182776. PubMed ID: 37342266
[TBL] [Abstract][Full Text] [Related]
13. Construction of an Immunity and Ferroptosis-Related Risk Score Model to Predict Ovarian Cancer Clinical Outcomes and Immune Microenvironment.
Wei C; Zhao G; Gao M; Liu Y; Lei P; Cao T
Front Biosci (Landmark Ed); 2023 Jan; 28(1):4. PubMed ID: 36722270
[TBL] [Abstract][Full Text] [Related]
14. Construction of a ceRNA network of hub genes affecting immune infiltration in ovarian cancer identified by WGCNA.
Su R; Jin C; Zhou L; Cao Y; Kuang M; Li L; Xiang J
BMC Cancer; 2021 Aug; 21(1):970. PubMed ID: 34461858
[TBL] [Abstract][Full Text] [Related]
15. TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway.
Sun T; Bi F; Liu Z; Yang Q
J Transl Med; 2021 Mar; 19(1):111. PubMed ID: 33731124
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.
Yan S; Fang J; Chen Y; Xie Y; Zhang S; Zhu X; Fang F
BMC Cancer; 2020 Dec; 20(1):1205. PubMed ID: 33287740
[TBL] [Abstract][Full Text] [Related]
17. Four genes relevant to pathological grade and prognosis in ovarian cancer.
Pan X; Chen Y; Gao S
Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
[TBL] [Abstract][Full Text] [Related]
18. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
Wu M; Sun Y; Wu J; Liu G
Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
[TBL] [Abstract][Full Text] [Related]
19. ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer.
Wang S; Zhang H; Liu H; Guo X; Ma R; Zhu W; Gao P
Med Oncol; 2021 Nov; 39(1):15. PubMed ID: 34817735
[TBL] [Abstract][Full Text] [Related]
20. Co-expression modules construction by WGCNA and identify potential hub genes and regulation pathways of postpartum depression.
Deng Z; Cai W; Liu J; Deng A; Yang Y; Tu J; Yuan C; Xiao H; Gao W
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1019-1030. PubMed ID: 34856750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
